2.84000 USD
0.3
11.81%
Last update Dec 16, 3:59 PM EST
Market closed
Day range
2.45000
2.90000
Previous close
2.54000
Open
2.5
Access this stock data via API
Subscribe
Perspective Therapeutics Inc.
2.84
0.30
11.81%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 20.3M 16.6M 14.3M 12.9M
Selling general and admin 7.7M 7.7M 7.8M 8.2M
Other operating expenses -209K -290K -342K -234K
Operating income -27.9M -24.0M -21.8M -20.9M
Non operating interest income
Income 2.0M 2.2M 2.4M 2.6M
Expense 65K 119K 128K -73K
Other income expense 1.4M -24.1M
Pretax income -26.0M -22.0M -18.2M -42.3M
Tax provision -2.1M
Net income -26.0M -21.5M -18.2M -40.2M
Basic EPS -0.4 -0.3 -0.3
Diluted EPS -0.4 -0.3 -0.3
Basic average shares 74.3M 74.2M 72.4M
Diluted average shares 74.3M 74.2M 72.4M
EBITDA -25.1M -21.1M -17.3M -17.5M
Net income from continuing op. -26.0M -21.5M -18.2M -40.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 51 minutes

20:08
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).